About the Company
We do not have any company description for Unicycive Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $UNCY News
Unicycive Therapeutics (UNCY) Price Target Increased by 21.14% to 5.41
The average one-year price target for Unicycive Therapeutics (NasdaqCM:UNCY) has been revised to 5.41 / share. This is an ...
Unicycive Therapeutics Inc (UNCY) Stock Showcases -11.30% 20-Day Moving Average
The stock of Unicycive Therapeutics Inc (UNCY) has seen a -14.38% decrease in the past week, with a -12.59% drop in the past month, and a 27.55% flourish in the past quarter. The volatility ratio for ...
Buy Rating Affirmed for Unicycive Therapeutics on Strong Trial Progress and Financial Positioning
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Unicycive Therapeutics (UNCY – Research Report). The associated ...
Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, ...
Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioMarin Pharmaceutical (BMRN – Research ...
DelveInsight Business Research, LLP: Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight
The increasing occurrence of kidney disorders worldwide and the healthcare sector's increased focus on consistent monitoring and effective management of these conditions are expected to drive ...
Loading the latest forecasts...